Jonathan Slonin, MD, PhD, serves as the Chief Medical Officer at Pacira BioSciences, Inc., a position he has held since joining the company in 2017. Dr. Slonin brings a wealth of expertise in clinical development and medical affairs, having previously worked in leadership roles at major pharmaceutical companies. Before joining Pacira, he was the Vice President and Head of Global Medical Affairs at Alexion Pharmaceuticals, where he played a pivotal role in advancing the company's portfolio of treatments for rare diseases. Dr. Slonin's academic credentials are equally impressive, with an MD from the University of Pennsylvania and a PhD in pharmacology from Yale University, underscoring his deep understanding of both clinical practice and scientific research. At Pacira BioSciences, Dr. Slonin is responsible for overseeing the clinical development and medical affairs strategies that drive the company's mission to provide innovative non-opioid pain management solutions. Under his leadership, Pacira has successfully expanded its product offerings, most notably with the development and commercialization of EXPAREL, a long-acting local anesthetic that has revolutionized postoperative pain management. Dr. Slonin's strategic vision has been instrumental in navigating the complex regulatory landscape and ensuring that Pacira's products meet the highest standards of safety and efficacy. His contributions have not only bolstered the company's growth but also significantly improved patient outcomes, making him a respected figure in the field of pain management.